darifenacin hydrobromide

FDA Drug Profile

darifenacin hydrobromide is listed in the FDA National Drug Code directory with 1 NDC code. Available dosage form: powder.

Drug details

Generic Name
darifenacin hydrobromide
Sponsor
Jubilant Biosys Limited
NDC Codes
1
Dosage Forms
POWDER
Active Ingredients
DARIFENACIN

Indications and Usage

1 INDICATIONS AND USAGE Darifenacin extended-release tablets are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency. ( 1 ) Darifenacin extended-release tablets are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.